Skip to main content
Image of syringe and pipets)

Therapeutic Areas and Products

Allergy and Immunology

Our world-leading immunoglobulin (Ig) franchise is the cornerstone of the immunology therapeutic area. Our efforts in this area focus on bringing trusted products and technologies to serve patients with a range of rare and serious diseases, including Primary Immunodeficiencies (PID) and Hereditary Angioedema (HAE).

Key Publications

PID

Safety and Efficacy of Privigen, a Novel 10% Liquid Immunogobulin Preparation for Intravenous Use, in patients with Primary Immunodeficiencies
Stein, MR et al
J Clin Immunol 2009

Request | Ask a Question


ITP

Efficacy and safety of Privigen®, a novel liquid intravenous immunoglobulin formulation in adolescent and adult patients with chronic immune thrombocytopenic purapura
Robak, T et al
Hematology 2009

Request | Ask a Question


For U.S. Healthcare Professionals only

The purpose of this CSL Behring Medical Affairs website is to support Healthcare Professionals with scientific information. This website is also a channel for U.S. Healthcare Professionals to submit questions or connect with CSL Behring U.S. Healthcare Professionals. The information provided is for educational purposes only and is not intended to promote any products. By continuing to use this site you are acknowledging that you are a US Healthcare Professional